<code id='FBDEB6628E'></code><style id='FBDEB6628E'></style>
    • <acronym id='FBDEB6628E'></acronym>
      <center id='FBDEB6628E'><center id='FBDEB6628E'><tfoot id='FBDEB6628E'></tfoot></center><abbr id='FBDEB6628E'><dir id='FBDEB6628E'><tfoot id='FBDEB6628E'></tfoot><noframes id='FBDEB6628E'>

    • <optgroup id='FBDEB6628E'><strike id='FBDEB6628E'><sup id='FBDEB6628E'></sup></strike><code id='FBDEB6628E'></code></optgroup>
        1. <b id='FBDEB6628E'><label id='FBDEB6628E'><select id='FBDEB6628E'><dt id='FBDEB6628E'><span id='FBDEB6628E'></span></dt></select></label></b><u id='FBDEB6628E'></u>
          <i id='FBDEB6628E'><strike id='FBDEB6628E'><tt id='FBDEB6628E'><pre id='FBDEB6628E'></pre></tt></strike></i>

          focus

          focus

          author:knowledge    Page View:6773

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          Relive this year’s J.P. Morgan Healthcare Conference with the STAT reporters who attended. Get a full rundown of the deals, data, and scuttlebutt and come away with the ideas and water-cooler chatter you need for the year ahead.

          advertisement

          Sponsor introduction

          • John Arena, SVP, enterprise strategy & solutions, Cencora

          Featured speakers

          • Tara Bannow, hospitals and insurance reporter, STAT
          • Damian Garde, national biotech reporter, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Allison DeAngelis, biotech startups and venture capital reporter, STAT (moderator)

          Sponsored By

          Cencora

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          Study suggests Covid rebound is far more common with Paxlovid than without
          Study suggests Covid rebound is far more common with Paxlovid than without

          AdobeAsmallandpreliminarystudypublishedMondayseemstoindicatethatpatientsreceivingthedrugPaxlovidaref

          read more
          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more

          Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

          LISELOTTESABROE/AFP/GettyImagesWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup tog